Our results suggest that women may have greater reserve, against their greater tau burden, allowing them to cope better with neurodegeneration and cognitive impairment at the beginning, but when they reach a certain threshold women’s cognitive decline is faster than men’s. The gene discussed is MAPT; the disease is Mental deterioration.